Citation Impact
Citing Papers
Efficient and Chemoselective Reduction of Pyridines to Tetrahydropyridines and Piperidines via Rhodium‐Catalyzed Transfer Hydrogenation
2012
Consensus Statement of the Movement Disorder Society on Tremor
2008 Standout
Comparative Pharmacology of Risperidone and Paliperidone
2015
Addition of Clonidine to Epidural Morphine Enhances Postoperative Analgesia After Cesarean Delivery
1995
Epidural Clonidine or Sufentanil for Intraoperative and Postoperative Analgesia
1995
Comparison of a bupivacaine-clonidine mixture with plain bupivacaine for caudal analgesia in children † †This paper was presented in part to the North East Thames Region Anaesthetists Society Meeting, April 24, 1993.
1994
An efficient synthesis of risperidonevia stille reaction: Antipsychotic, 5-HT2, and dopamine-D2-antagonist
2005
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
5-Hydroxytryptamine pathways in anxiety and its treatment
1995
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double‐blind parallel‐group trial
1995
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography
1993
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Sensory Innervation of the Dorsal Portion of the Lumbar Intervertebral Disc in Rats
1999 StandoutNobel
The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis
1995
Risperidone versus haloperidol: I. meta-analysis of efficacy and safety
1998
Estrogen control of central neurotransmission: Effect on mood, mental state, and memory
1996
Functional study of rat 5‐HT2A receptors using antisense oligonucleotides
2003
Mechanisms of action of atypical antipsychotic drugs
1991
Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors
2000
5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions
1993
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Guillain-Barré syndrome
2016 Standout
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine?s actions?
2004
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage
1990
A new wave of serotonin receptors
1993 StandoutNobel
Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors
1988
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
1995
Levocabastine: Pharmacological profile of a highly effective inhibitor of allergic reactions
1992
The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4
2015
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
Risperidone
2012
α2-Adrenergic Agonists for Regional Anesthesia
1996 Standout
Recent advances in transition-metal-free carbon–carbon and carbon–heteroatom bond-forming reactions using arynes
2012 Standout
Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens
1996
Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase
2013
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
2003 Standout
A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development
1995
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Mitotoxicity in distal symmetrical sensory peripheral neuropathies
2014
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
1990 Nature
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
A limited arthritic model for chronic pain studies in the rat
1992
The Serotonin Syndrome
2005 Standout
Oral cocaine seeking by rats: Action or habit?
2003
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
CLONIDINE COMBINED WITH SUFENTANIL AND BUPIVACAINE WITH ADRENALINE FOR OBSTETRIC ANALGESIA
1993
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis
1997
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
1996
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
2020
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
The neural basis of psychedelic action
2022 Standout
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Pharmacologically active compounds in the environment and their chirality
2010
Clinical utility of the risperidone formulations in the management of schizophrenia
2011
Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests
1997
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Relating protein pharmacology by ligand chemistry
2007 Standout
Mechanisms of distal axonal degeneration in peripheral neuropathies
2015
The psychopharmacology of 5-HT3 receptors
1990
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ‘atypical’ antipsychotics, clozapine and risperidone
1994
Psychiatric Aspects of Impulsivity
2001 Standout
Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
1995
Vascular endothelial growth factor: a neurovascular target in neurological diseases
2016
The role of aberrant mitochondrial bioenergetics in diabetic neuropathy
2012
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
LSD, 5-HT (serotonin), and the evolution of a behavioral assay
2003
A Double-Blind Pilot Study of Risperidone in the Treatment of Conduct Disorder
2000
Preparation and in-vitro release rate of fentanyl–cyclodextrin complexes for prolonged action in epidural analgesia
2003
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
1991 StandoutNature
Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
2018
Estrogen Actions in the Central Nervous System1
1999 Standout
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis
2005
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
2012
Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptors
1990
Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex
1989
Transient Receptor Potential Channels in neuropathic pain
2016
Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats
1987
Iron Catalysis in Organic Synthesis
2015 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
The Golden Age of Transfer Hydrogenation
2015 Standout
Estrogen increases the density of 5-Hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat
1995
Synthesis of Benzisoxazoles by the [3 + 2] Cycloaddition ofin situGenerated Nitrile Oxides and Arynes
2010
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
2018
An Updated Understanding of the Mechanisms Involved in cHemotherapy-Induced Neuropathy
2018
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
1993 StandoutNobel
Cyclodextrin Drug Carrier Systems
1998 Standout
Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: Blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist
1994
Conformationally Constrained Dipeptide Surrogates with Aromatic Side-Chains: Synthesis of 4-Aryl Indolizidin-9-one Amino Acids by Conjugate Addition to a Common α,ω-Diaminoazelate Enone Intermediate
2004
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Theoretical Studies on N–O or N–N Bond Formation from Aryl Azide Catalyzed by Iron(II) Bromide Complex
2012
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Catalytic Asymmetric Conjugate Addition and Allylic Alkylation with Grignard Reagents
2008 StandoutNobel
Risperidone
1994
Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors
1987
Mechanisms of Diabetic Complications
2013 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists
1986
Remarkable asymmetric induction from remote stereocenters in conjugate addition chemistry for the synthesis of alkyl‐branched α, ω‐diaminoazelates
2001
The Use of Hallucinogens in the Treatment of Addiction
1996
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Effects of the complexation of various fentanyl analogs in hydroxypropyl‐β‐cyclodextrin after epidural and intrathecal administration in rats
1993
Dopamine Receptors: From Structure to Function
1998 Standout
Host–Guest Interactions of Risperidone with Natural and Modified Cyclodextrins: Phase Solubility, Thermodynamics and Molecular Modeling Studies
2005
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Hallucinogens
2004 Standout
Works of T. Meert being referenced
2012
Survey on the pharmacodynamics of the new antipsychotic risperidone
1994
Patient‐controlled epidural analgesia with sufentanil following Caesarean section: the effect of adrenaline and clonidine admixture
1994
Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies
2013
Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats
1997
Comparison of epidural sufentanil plus clonidine with sufentanil alone for postoperative pain relief
1990
Ritanserin Reduces Abuse of Alcohol, Cocaine, and Fentanyl in Rats
1991
A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies
2012
Evidence for a Possible Role of the 5‐HT2 Antagonist Ritanserin in Drug Abuse
1992
Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats
1989
Spinal sufentanil in rats: Part III: Effect of diluent volume on epidural sufentanil
1992
Interactions between the lipophilic opioid sufentanil and clonidine in rats after spinal application
1995
Spinal sufentanil in rats: part I: epidural versus intrathecal sufentanil and morphine
1992
Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat
2011
Probing opioid receptor–ligand interactions by employment of indolizidin‐9‐one amino acid as a constrained Gly2‐Gly3 surrogate in a leucine‐enkephalin mimic
2001
Behavioural activity of rats measured by a new method based on the piezo-electric principle
1987
Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
1992
Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat
1982
Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat
1985
PHARMACOLOGICAL EVALUATION OF ALCOHOL WITHDRAWAL-INDUCED INHIBITION OF EXPLORATORY BEHAVIOUR AND SUPERSENSITIVITY TO HARMINE-INDUCED TREMOR
1994
Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
1988
Ritanserin, a new therapeutic approach for drug abuse. Part 2: Effects on cocaine
1992
Ritanserin overcomes exploratory inhibition induced by cocaine withdrawal
1992
Psychopharmacology of ritanserin: Comparison with chlordiazepoxide
1989